This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
12 Aug 2021 | North America | Market Research
Frost Radar™: Non-Invasive Prenatal Testing, Global, 2021
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
Non-invasive prenatal testing (NIPT) provides an alternative to invasive, higher-risk tests such as amniocentesis, requiring a maternal blood sample to obtain cell-free DNA from both mother and fetus for analysis. Since NIPTs debut in 2011, laboratories and testing companies have made incremental upgrades to their non-invasive screens, improving ac...
$4,950.00 -
23 Jun 2021 | Global | Market Research
Frost Radar™: Artificial Intelligence-enabled Drug Discovery in the Global Pharmaceutical Industry, 2021
A Benchmarking System to Spark Companies to Action—Innovation that Fuels New Deal Flow and Growth Pipelines
Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...
$4,950.00 -
20 Nov 2012 | North America | Market Research
The U.S. Health Information Exchange Market
A Comprehensive Guide to Market Dynamics, Technology Vendors, and Future Trends
This study provides a roadmap for understanding health information exchange. We provide an in-depth overview of the technical aspects of health information exchange (HIE), review major government initiatives driving health information exchange efforts across the U.S., define and describe the major market segments and subsegments, and look at rece...
$4,950.00 -
27 Sep 2012 | Europe | Market Research
European Alzheimers Disease Medication Market
Launch of Disease-modifying Drugs expected to Boost Market Growth
The key objective of this research service is to study the European Alzheimers disease medication market based on the three major classes of drugs namely acetylcholinesterase inhibitors, NMDA receptor antagonists and new mechanism/ disease modifying drugs and identify the key current and future trends shaping these market segments. It also aims...
$4,950.00 -
31 Aug 2012 | Asia Pacific | Market Research
Strategic Analysis of Contract Research and Manufacturing Services Market in India
Presenting Opportunities for Market Share Gain
This study provides a comprehensive analysis of the contract research and manufacturing services (CRAMS) segment in India by focusing on drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectables. The study is based on detailed primary research, and includes an evaluation of the market size as ...
$4,950.00 -
15 May 2012 | North America | Market Research
Mölnlycke Health Care—Company Profile
This market insight provides an overview of Mölnlycke Health Care. The Mölnlycke company was established in 1849 by G.F. Henning as primarily a textile manufacturer. In 1997, Mölnlycke Health Care came in to existence when Nordic Capital acquired the medical devices segment of SCA. The company is currently owned by Investor AB and has seen stea...
$1,500.00
